Bendazac
Back to searchMolecule Structure
Scientific Name
Bendazac
Description of the Drug
Bendazac is a non-steroidal anti-inflammatory drug (NSAID) available as an eye drop for the treatment of cataracts and as a topical cream for the treatment of dermatitis, eczema, hives, skin ulcers and other inflammatory skin conditions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13501
http://www.drugbank.ca/drugs/DB13501
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Xanthine dehydrogenase | SINGLE PROTEIN | INHIBITOR | CHEMBL1929 |
Clinical Trial(s)
Unichem Links
Atlas | bendazac |
SureChEMBL | SCHEMBL25979 |
Human Metabolome Database | HMDB0248946 |
DrugBank | DB13501 |
PubChem: Thomson Pharma | 14799718 |
PubChem | 2313 |
Nikkaji | J3.148H |
EPA CompTox Dashboard | DTXSID1048334 |
DrugCentral | 303 |
ChemicalBook | CB4222435 |
ChEBI | 31257 |
ZINC | ZINC000000001000 |